- Suchergebnis für K04498
Cookie-Einstellungen
Diese Website benutzt Cookies, die für den technischen Betrieb der Website erforderlich sind und stets gesetzt werden. Andere Cookies, die den Komfort bei Benutzung dieser Website erhöhen, der Direktwerbung dienen oder die Interaktion mit anderen Websites und sozialen Netzwerken vereinfachen sollen, werden nur mit Ihrer Zustimmung gesetzt.
Konfiguration
Technisch erforderlich
Diese Cookies sind für die Grundfunktionen des Shops notwendig.
"Alle Cookies ablehnen" Cookie
"Alle Cookies annehmen" Cookie
Ausgewählter Shop
CSRF-Token
Cookie-Einstellungen
FACT-Finder Tracking
Individuelle Preise
Kundenspezifisches Caching
Session
Währungswechsel
Komfortfunktionen
Diese Cookies werden genutzt um das Einkaufserlebnis noch ansprechender zu gestalten, beispielsweise für die Wiedererkennung des Besuchers.
Facebook-Seite in der rechten Blog - Sidebar anzeigen
Merkzettel
Statistik & Tracking
Endgeräteerkennung
Kauf- und Surfverhalten mit Google Tag Manager
Partnerprogramm
Zu "K04498" wurden 165 Artikel gefunden!
Filter schließen
Filtern nach:
Für die Filterung wurden keine Ergebnisse gefunden!
Artikelnummer: Cay41728-10
PRI-724 is a prodrug form of the beta-catenin/CREB-binding protein (CBP) inhibitor C-82 and a derivative of ICG-001 (Cay-16257). It is cytotoxic to GES-1 gastric mucosal and HGC-27, MKN45, and AGS gastric cancer cells (IC50s = 16.53, 9.8, 44.28, and 3.48 µM, respectively) and enhances decreases in viability induced...
Schlagworte: | (6S,9S,9aS)-hexahydro-2,9-dimethyl-4,7-dioxo-N-(phenylmethyl)-6-[[4-(phosphonooxy)phenyl]methyl]-8-(8-quinolinylmethyl)-2H... |
Anwendung: | C-82 (CREB-binding protein inhibitor) prodrug |
CAS | 1422253-38-0 |
MW: | 658.7 D |
ab 75,00 €
Artikelnummer: TGM-TMPH-01158-100ug
Description: CREBBP Protein, Human, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 40.7 kDa and the accession number is Q92793.
Schlagworte: | CREB-binding protein, CBP, CREBBP |
MW: | 40.7 kD |
ab 236,00 €
Artikelnummer: TGM-T6668-100mg
Description: SGC-CBP30 is an effective CREBBP/EP300 inhibitor (IC50: 21/38 nM). Target: Histone Acetyltransferase, Epigenetic Reader Domain. Smiles: COc1ccc(CCc2nc3cc(ccc3n2C[C@H](C)N2CCOCC2)-c2c(C)noc2C)cc1Cl. References: Structural Genomics Consortium
Anwendung: | CREBBP / EP300 bromodomain inhibitor |
CAS | 1613695-14-9 |
MW: | 509.04 D |
ab 45,00 €
Artikelnummer: TGM-T6389-100mg
Description: Anacardic Acid (6-pentadecylsalicylic Acid) is an effective inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases. It also has antimicrobial activity, antibacterial activity, and inhibits prostaglandin synthase, lipoxygenase, and tyrosinase. Target: Epigenetic Reader Domain,...
Schlagworte: | 6-pentadecylsalicylic Acid, Hydroginkgolic acid |
Anwendung: | HAT inhibitor |
CAS | 16611-84-0 |
MW: | 348.52 D |
ab 45,00 €
Artikelnummer: TGM-T6811-100mg
Description: CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor. Target: Histone Acetyltransferase, Epigenetic Reader Domain. Smiles: C[C@@H]1CC(=O)Nc2cccc(-c3ccc4n(C)nc(-c5cnn(C)c5)c4c3)c2N1. References: Taylor AM, et al. ACS Med Chem Lett. 2016, 7(5):531-6.
Schlagworte: | CPI 637 |
Anwendung: | CREB-binding protein / Histone acetyltransferase p300 inhibitor |
CAS | 1884712-47-3 |
MW: | 386.45 D |
ab 34,00 €
Artikelnummer: TGM-T11563-100mg
Description: Histone Acetyltransferase Inhibitor II is a selective and cell permeable inhibitor of p300 histone acetyltransferase(IC50 : 5 µM).with anti-acetylase activity in mammalian cells. Target: Epigenetic Reader Domain, Histone Acetyltransferase. Smiles: Oc1ccc(\C=C2/CCC\C(=C/c3ccc(O)c(Br)c3)C2=O)cc1Br....
Anwendung: | Histone Acetyltransferase (p300) inhibitor |
CAS | 932749-62-7 |
MW: | 464.15 D |
ab 31,00 €
Artikelnummer: TGM-T11807-100mg
Description: L002, a potent, cell-permeable, reversible, and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 µM, directly binds the acetyl-CoA pocket and competitively inhibits the FATp300 catalytic domain. By blocking histone acetylation, p53 acetylation, and STAT3 activation, L002 shows...
Anwendung: | p300 histone acetyltransferase inhibitor |
CAS | 321695-57-2 |
MW: | 321.35 D |
ab 34,00 €
Artikelnummer: TGM-T14073-100mg
Description: A-485 is a potent and selective catalytic p300/CBP inhibitor with IC50 values of 9.8 nM for p300 and 2.6 nM for CBP. Target: Epigenetic Reader Domain, Histone Acetyltransferase. Smiles: CNC(=O)Nc1ccc2c(CC[C@@]22OC(=O)N(CC(=O)N(Cc3ccc(F)cc3)[C@@H](C)C(F)(F)F)C2=O)c1. References: Lasko LM, et al....
Anwendung: | p300/CBP inhibitor |
CAS | 1889279-16-6 |
MW: | 536.48 D |
ab 88,00 €
Artikelnummer: TGM-T15014-10mg
Description: CTPB is a potent p300 histone acetyltransferase (HAT) activator that can be used in the preparation of hair growth promoters and/or hair loss treatments. Target: Histone Acetyltransferase. Smiles: CCCCCCCCCC CCCCCc1cccc(OCC)c1C(=O)Nc1ccc(Cl)c(c1)C(F)(F)F. References: Sivanandam M, et al. Investigation...
Anwendung: | Potent p300 activator |
CAS | 586976-24-1 |
MW: | 554.13 D |
ab 63,00 €
Artikelnummer: TGM-T15405-100mg
Description: GNE-781 is a highly potent and selective inhibitor of CBP (IC50: 0.94 nM in TR-FRET assay). GNE-781 also inhibits BRET and BRD4(1) (IC50s: 6.2 nM and 5100 nM, respectively). Target: Epigenetic Reader Domain. Smiles: CNC(=O)N1CCc2c(C1)c(nn2C1CCOCC1)N1CCCc2cc(-c3cnn(C)c3)c(cc12)C(F)F. References: Romero...
Anwendung: | CBP / p300 inhibitor |
CAS | 1936422-33-1 |
MW: | 525.59 D |
ab 164,00 €
Artikelnummer: TGM-T3969-100mg
Description: I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor targeting the CBP/p300 bromodomains. Target: Histone Acetyltransferase, Epigenetic Reader Domain. Smiles: CCC(=O)N1CCOc2c(C1)cc(cc2OC[C@H]1CCCN(C)C1)-c1ccc(OC)c(OC)c1. References: Zucconi BE, et al....
Anwendung: | P300 / CBP inhibitor |
CAS | 1640282-31-0 |
MW: | 468.59 D |
ab 30,00 €
Artikelnummer: TGM-T4247-100mg
Description: I-CBP112 is a selective inhibitor of the bromodomain-containing transcription factors. I-CBP112 (1 mM) has little activity against other bromodomains. I-CBP112 targets the CBP/p300 bromodomains. I-CBP112 significantly reduced the leukemia-initiating potential of MLL-AF9(+) acute myeloid leukemia cells...
Anwendung: | CBP and EP300 inhibitor |
CAS | 2147701-33-3 |
MW: | 505.05 D |
ab 83,00 €